BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 15542728)

  • 1. Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis.
    Ujike H; Sato M
    Ann N Y Acad Sci; 2004 Oct; 1025():279-87. PubMed ID: 15542728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Increasing prevalence of amphetamine--and methamphetamine-induced psychosis].
    Härtel-Petri R; Rodler R; Schmeisser U; Steinmann J; Wolfersdorf M
    Psychiatr Prax; 2005 Jan; 32(1):13-7. PubMed ID: 15633070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association study of the dihydropyrimidinase-related protein 2 gene and methamphetamine psychosis.
    Ujike H; Sakai A; Nakata K; Tanaka Y; Kodaka T; Okahisa Y; Harano M; Inada T; Yamada M; Komiyama T; Hori T; Sekine Y; Iwata N; Sora I; Iyo M; Ozaki N; Kuroda S
    Ann N Y Acad Sci; 2006 Aug; 1074():90-6. PubMed ID: 17105906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No association between CART (cocaine- and amphetamine-regulated transcript) gene and methamphetamine dependence.
    Morio A; Ujike H; Nomura A; Tanaka Y; Morita Y; Otani K; Kishimoto M; Harano M; Inada T; Komiyama T; Yamada M; Sekine Y; Iwata N; Iyo M; Sora I; Ozaki N; Kuroda S
    Ann N Y Acad Sci; 2006 Aug; 1074():411-7. PubMed ID: 17105939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of psychotic symptoms among methamphetamine users.
    McKetin R; McLaren J; Lubman DI; Hides L
    Addiction; 2006 Oct; 101(10):1473-8. PubMed ID: 16968349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical features of recent methamphetamine abusers: comparison between smoking abusers and injection abusers].
    Matsumoto T
    Seishin Shinkeigaku Zasshi; 2000; 102(5):498-513. PubMed ID: 10897680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhalant abusers and psychiatric symptoms].
    Okudaira K; Yabana T; Takahashi H; Iizuka H; Nakajima K; Saito A
    Seishin Shinkeigaku Zasshi; 1996; 98(4):203-12. PubMed ID: 8710994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse childhood experiences and interaction with methamphetamine use frequency in the risk of methamphetamine-associated psychosis.
    Ding Y; Lin H; Zhou L; Yan H; He N
    Drug Alcohol Depend; 2014 Sep; 142():295-300. PubMed ID: 25064022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A study on methamphetamine psychosis in a psychiatric clinic--comparison of acute and chronic-type cases].
    Teraoka A
    Seishin Shinkeigaku Zasshi; 1998; 100(7):425-68. PubMed ID: 9778996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substance misuse and early psychosis.
    Tucker P
    Australas Psychiatry; 2009 Aug; 17(4):291-4. PubMed ID: 19301164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical characteristics of dappou herb use--disorder patients at the drug dependence clinic: a comparison with methamphetamine use-disorder patients].
    Tanibuchi Y; Matsumoto T; Kobayashi O; Wada K
    Seishin Shinkeigaku Zasshi; 2013; 115(5):463-76. PubMed ID: 23855225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of methamphetamine use disorder treated with the antibiotic drug minocycline.
    Tanibuchi Y; Shimagami M; Fukami G; Sekine Y; Iyo M; Hashimoto K
    Gen Hosp Psychiatry; 2010; 32(5):559.e1-3. PubMed ID: 20851278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants of D2 but not D3 or D4 dopamine receptor gene are associated with rapid onset and poor prognosis of methamphetamine psychosis.
    Ujike H; Katsu T; Okahisa Y; Takaki M; Kodama M; Inada T; Uchimura N; Yamada M; Iwata N; Sora I; Iyo M; Ozaki N; Kuroda S
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):625-9. PubMed ID: 19275926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deterioration of intelligence in methamphetamine-induced psychosis: comparison with alcohol dependence on WAIS-III.
    Lin SK; Huang MC; Lin HC; Pan CH
    Psychiatry Clin Neurosci; 2010 Feb; 64(1):4-9. PubMed ID: 19968830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of inpatients with methamphetamine-induced psychosis.
    Fasihpour B; Molavi S; Shariat SV
    J Ment Health; 2013 Aug; 22(4):341-9. PubMed ID: 23323572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal clinical course following pharmacological treatment of methamphetamine psychosis which persists after long-term abstinence.
    Akiyama K
    Ann N Y Acad Sci; 2006 Aug; 1074():125-34. PubMed ID: 17105910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nonsynonymous polymorphism in the human fatty acid amide hydrolase gene did not associate with either methamphetamine dependence or schizophrenia.
    Morita Y; Ujike H; Tanaka Y; Uchida N; Nomura A; Ohtani K; Kishimoto M; Morio A; Imamura T; Sakai A; Inada T; Harano M; Komiyama T; Yamada M; Sekine Y; Iwata N; Iyo M; Sora I; Ozaki N; Kuroda S
    Neurosci Lett; 2005 Mar; 376(3):182-7. PubMed ID: 15721218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiles associated with treatment retention in Japanese patients with methamphetamine use disorder: preliminary survey.
    Kobayashi O; Matsumoto T; Otsuki M; Endo K; Okudaira K; Wada K; Hirayasu Y
    Psychiatry Clin Neurosci; 2008 Oct; 62(5):526-32. PubMed ID: 18950371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An exploratory analysis of neurocognition in methamphetamine-induced psychotic disorder and paranoid schizophrenia.
    Jacobs E; Fujii D; Schiffman J; Bello I
    Cogn Behav Neurol; 2008 Jun; 21(2):98-103. PubMed ID: 18541986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nine- or fewer repeat alleles in VNTR polymorphism of the dopamine transporter gene is a strong risk factor for prolonged methamphetamine psychosis.
    Ujike H; Harano M; Inada T; Yamada M; Komiyama T; Sekine Y; Sora I; Iyo M; Katsu T; Nomura A; Nakata K; Ozaki N
    Pharmacogenomics J; 2003; 3(4):242-7. PubMed ID: 12931138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.